Requiring insurance to cover certain nutrition and dietary needs
HB4760 would require a range of West Virginia health insurance arrangements to cover or reimburse dietary supplements when they are recommended by an enrollee’s health care provider. The bill adds nearly identical coverage language to the Public Employees Insurance Act, human services provisions, and multiple insurance code chapters governing accident and sickness insurance, group insurance, hospital medical and dental corporations, healthcare corporations, and health maintenance organizations. The coverage mandate would apply to policies, plans, or contracts issued or renewed on or after January 1, 2027.
The bill defines “dietary supplement” by reference to the federal Dietary Supplement Health and Education Act of 1994 and includes products such as vitamins, minerals, herbs, botanicals, amino acids, enzymes, prebiotics, probiotics, extracts, and similar substances, so long as they are labeled as dietary supplements and not conventional food. The stated purpose is to improve health, reduce health care usage and costs, prevent disease through nutritional wellness and prevention measures, and provide nonpharmacological alternatives for enrollees who choose them.
HB4760 would expand mandated insurance benefits in West Virginia by requiring coverage or reimbursement for qualifying dietary supplements across both public and private health plans covered by the listed statutes. It would affect PEIA, certain human services coverage provisions, and several categories of regulated health insurance products, likely increasing insurer and plan administrator obligations to process supplement claims when supported by a provider recommendation. The bill does not create a general right to all supplements, but it would embed a new statutory coverage requirement into multiple chapters of state insurance law.
Based on the bill text and available context, the measure appears to be framed positively as a health-promotion and prevention bill rather than a cost-cutting or regulatory rollback measure. The caption and purpose statement emphasize nutritional wellness, disease prevention, and nonpharmacological options, suggesting support from sponsors and the originating health committee for expanding access to provider-recommended supplements. No committee transcript or vote record was provided, so there is no documented opposition or recorded floor sentiment in the supplied materials.
The main likely point of contention is cost and scope: insurers and public plans may object to a new mandated benefit for dietary supplements, especially because the bill covers a broad range of products and applies whenever a provider recommends them. Another possible issue is administrative and medical-necessity oversight, since the bill relies on provider recommendation and a broad federal definition that could raise questions about which products qualify and how claims would be verified. Supporters would likely emphasize preventive care, patient choice, and alternatives to pharmaceuticals, while critics would likely focus on premium impacts, coverage boundaries, and the potential for expanded utilization.